How Red Light Therapy Affects Blood Clots

Red light therapy, technically called photobiomodulation, appears to shift blood chemistry in ways that discourage clot formation. Laboratory and animal studies consistently show that red and near-infrared wavelengths reduce platelet stickiness, promote the release of nitric oxide (a natural blood-vessel relaxer), and dampen inflammation that can trigger clotting cascades. A 2025 review in a thrombosis journal described the experimental evidence as showing reduced platelet aggregation, lower von Willebrand factor activity, and improved microvascular blood flow. But “appears to” and “experimental” are doing heavy lifting in those sentences, because the vast majority of this research has been done in test tubes, on isolated blood samples, or in animal models rather than in people with actual clot-related conditions.

What Red Light Does to Platelets

Platelets are the small cell fragments responsible for forming the initial plug when you cut yourself. They are also the culprits behind dangerous clots inside blood vessels. When platelets become overactive, they aggregate, or clump together, more readily than they should. Several independent research groups have found that exposing blood to red or near-infrared light makes platelets less eager to aggregate.

A study using long-wavelength red light found that exposure resulted in reduced platelet aggregation and activation compared to other light wavelengths or darkness.¹ Separately, researchers testing laser irradiation on human platelet samples found that all tested doses significantly reduced aggregation, with the strongest effect at a specific energy density. Interestingly, that study found no change in the usual platelet activation markers or nitric oxide pathway compounds, suggesting the anti-clumping effect works through some mechanism other than the one most commonly proposed.²

A more dramatic demonstration came from research on cardiopulmonary bypass, the heart-lung machine used during open-heart surgery. Blood circulating through bypass tubing takes a beating: the artificial surfaces and mechanical shear stress destroy platelets and activate clotting. When researchers applied low-level light therapy to the circulating blood, platelet counts stayed higher, aggregation patterns stabilized, and surface markers of platelet activation held steady rather than fluctuating wildly as they did in untreated blood.³ The researchers proposed that the light helped preserve mitochondrial function inside the platelets, essentially keeping the cells’ energy supply intact so they could resist the damage caused by the artificial circuit.⁴

Nitric Oxide and Blood Vessel Relaxation

One of the leading explanations for how red light influences clotting involves nitric oxide, the molecule your blood vessel walls release to widen arteries and keep blood flowing smoothly. Nitric oxide also naturally discourages platelets from sticking to vessel walls and to each other. Multiple research groups have found that red light triggers the release of stored nitric oxide compounds from the cells lining blood vessels.

In one set of experiments, researchers exposed endothelial cells to red light and measured a significant increase in S-nitrosothiols, a stored form of nitric oxide, in the fluid surrounding the cells. At the same time, levels inside the cells dropped, indicating the nitric oxide stores were being pushed outward into the bloodstream rather than created from scratch.⁵ This released nitric oxide was packaged inside tiny membrane-bound particles called extracellular vesicles, which could then travel downstream and dilate blood vessels at a distance from the light source. A related study confirmed the presence of these nitric oxide-carrying compounds using a chemical detection method and showed that the signal was consistent with S-nitrosothiols or a related iron-based nitric oxide complex.⁶

Why this matters for clots: wider, more relaxed blood vessels with adequate nitric oxide are less hospitable to clot formation. Blood moves faster, platelets are chemically discouraged from aggregating, and the vessel wall itself stays in a healthier, less “sticky” state. In a diabetes model, red light even rescued impaired blood vessel dilation, which is notable because diabetes is a major risk factor for pathological clotting.⁶

Effects on Red Blood Cells and Blood Flow

Clot risk is not only about platelets. How easily blood flows through vessels matters too, and red blood cells play a starring role in that. Stiff, damaged red blood cells make blood thicker and more sluggish, which encourages clotting in small vessels. Research on extracorporeal circulation found that near-infrared light increased red blood cell membrane fluidity, making the cells more deformable and better able to squeeze through capillaries. This improvement in what researchers call “rheological properties” has been confirmed across multiple studies.⁷

That said, the rheological picture is not uniformly positive. A study using pulsed infrared light on blood samples from patients found only a modest decrease in one viscosity measurement, with other parameters showing a weak trend toward lower values that did not reach significance. The researchers described the infrared light effect on blood flow properties as “rather neutral” in their study group.⁸ This inconsistency is worth keeping in mind: wavelength, pulse pattern, and dose all seem to matter, and what works in one experimental setup may not transfer cleanly to another.

Fibrinogen and Clot Architecture

Fibrinogen is the protein that forms the mesh-like scaffold of a clot. When it gets converted into fibrin strands, those strands weave together to trap blood cells and solidify the plug. Research has found that treating plasma with red light alters fibrinogen in ways that slow down clot formation. Specifically, treated plasma showed prolonged clotting time and fibrin fibers with a lower mass-to-length ratio, meaning thinner, less densely packed strands. Importantly, the resulting clot was still structurally stable and broke down normally, so the light was not disabling the clotting system, just dialing it back.⁹

A 2025 randomized controlled trial added a clinical data point. In that trial, red-light intravenous laser blood irradiation reduced fibrinogen levels by about 28 mg/dL compared to baseline in the overall group. When the researchers split participants by age, younger adults showed a fibrinogen drop of roughly 30 mg/dL alongside a decrease in the inflammatory marker IL-6, while older adults saw shifts primarily in red blood cell indices rather than fibrinogen.¹⁰ This age-dependent split is a reminder that the body’s response to photobiomodulation is not uniform across populations.

Inflammation as a Clotting Trigger

Inflammation and clotting are deeply intertwined. Inflammatory molecules activate clotting pathways, and clot formation itself releases more inflammatory signals, creating a feedback loop that thrombosis researchers call “thromboinflammation.” Red light has shown promise in breaking this cycle, at least in animal experiments.

In a mouse polytrauma model, pre-exposure to red light dramatically reduced inflammation after injury. Mice exposed to red light before being subjected to polytrauma had plasma IL-6 levels roughly a third of those in the blue-light group, and their MCP-1 concentrations (another inflammatory marker) were about half those seen in the ambient-light control group.¹¹ Lower systemic inflammation after injury would be expected to reduce the activation of clotting cascades, though the study focused on measuring inflammatory markers and organ injury rather than clot formation directly.

This aligns with a broader pattern described in a 2025 review, which framed red light therapy’s anti-thrombotic potential in terms of Virchow’s triad, the classic model describing three conditions that promote abnormal clotting: damage to the blood vessel wall, sluggish blood flow, and a hypercoagulable state. The review argued that photobiomodulation addresses all three legs of the triad by improving endothelial function, enhancing microvascular perfusion, and reducing platelet hyperactivity.¹²

How Red Light Affects the Blood Vessel Wall

Healthy endothelial cells, the layer lining every blood vessel, actively prevent clots by producing nitric oxide, by repelling platelets, and by quickly repairing damage. When endothelial cells are injured or dysfunctional, clot risk rises sharply. Red light has been shown to support endothelial health in laboratory experiments. In one study, endothelial cells exposed to red LED light proliferated roughly 44% more than untreated controls over 72 hours. Red light also enhanced cell migration: about 53 cells migrated away from bead-based assay clusters in the red-light group compared to roughly 20 in untreated controls, a nearly threefold increase. Wound-closure assays showed that red light accelerated the rate at which an endothelial cell layer sealed itself, reducing the wound area by about 37% in six hours compared to roughly 29% for untreated cells.¹³

Faster endothelial repair and growth could theoretically reduce clot risk by keeping the vessel lining intact and functional. A damaged vessel wall exposes collagen and other proteins that platelets bind to, so anything that helps the wall heal quickly shrinks the window of vulnerability. This is still theoretical as applied to living patients, but it adds another mechanism to the list.

Intravenous Laser Blood Irradiation

Most red light therapy is applied through the skin. But a technique called intravenous laser blood irradiation, or ILIB, threads a thin fiber-optic cable into a vein and delivers light directly to flowing blood. This approach bypasses the problem of light being absorbed by skin and tissue before reaching blood vessels. A systematic review of ILIB research described multiple biological effects, including improved blood flow properties, enhanced oxygen-carrying capacity of red blood cells, immune regulation, and reduced inflammation and oxidative stress.¹⁴

The randomized trial mentioned earlier used ILIB to compare red and blue wavelengths directly. Red-light ILIB at 650 nm reduced red blood cell count, hematocrit, and fibrinogen from baseline, while blue-light ILIB at 415 nm did not produce the same shifts.¹⁰ Lower hematocrit means slightly thinner blood, and lower fibrinogen means less raw material for clot scaffolding. Both shifts would be expected to reduce clot risk modestly. ILIB is practiced in some countries, particularly in parts of Europe, Asia, and South America, but it is not widely adopted or approved in the United States for thrombosis-related indications.

Wavelength, Dose, and Penetration Depth

Not all “red light” is the same, and the details matter considerably. Visible red light spans roughly 620 to 700 nanometers, and near-infrared runs from about 700 to 1,100 nm. These wavelengths behave differently in tissue. Near-infrared penetrates deeper because it is absorbed less by water and hemoglobin, while visible red is absorbed more readily near the surface. A computational study confirmed that both wavelength and the width of the light beam affect how deeply energy penetrates, which determines whether the light can actually reach blood vessels or stays trapped in the upper layers of skin and fat.¹⁵

One study that found near-infrared light inhibited platelet reactivity and reduced red blood cell destruction noted that its light source delivered 86% near-infrared radiation and 14% visible red light, making it primarily a near-infrared treatment.¹⁶ The platelet study that used visible red laser light alone also found strong anti-aggregation effects, so both windows seem to be active, possibly through overlapping but not identical mechanisms.²

Dose also follows a pattern familiar throughout photobiomodulation research: too little light does nothing useful, the right amount produces the desired effect, and too much can be counterproductive or even harmful. This biphasic response means you cannot simply crank up the power and expect better results. The most effective dose in the platelet aggregation study was a specific moderate energy density, with both lower and higher doses producing weaker effects.²

Consumer Panels Versus Research-Grade Equipment

If you are reading about red light therapy and clots, you are probably wondering whether the LED panel in your home gym or the red light bed at a wellness spa could actually affect your blood. The honest answer is that nobody knows with confidence. A review in a plastic surgery journal noted that it remains unclear whether LED-based consumer devices produce physiological effects comparable in nature and size to those seen with the laser-based systems used in most of the higher-quality research.¹⁷

The gap between lab conditions and consumer use is wide. In many of the studies discussed here, light was applied directly to blood flowing through transparent tubing, or to cells sitting in a dish with no skin, fat, or muscle in the way. The intravenous technique skips tissue entirely by delivering light inside the vein. A consumer LED panel shining on your forearm has to push photons through millimeters of skin and subcutaneous tissue before any light reaches a blood vessel, and the fraction that arrives is dramatically reduced. Whether enough energy survives that journey to meaningfully affect platelet function or nitric oxide release in a living person has not been established in rigorous clinical trials.

Practical Cautions for People With Clotting Conditions

The anti-platelet and anti-coagulant effects observed in the lab are modest under controlled conditions, but they raise a reasonable concern for anyone already on blood-thinning medication. If red light does reduce platelet aggregation and lower fibrinogen, even slightly, stacking that effect on top of warfarin, direct oral anticoagulants, or antiplatelet drugs like aspirin and clopidogrel could theoretically increase bleeding risk. No clinical trials have tested this combination directly, which means neither safety nor danger has been demonstrated in patients.

Conversely, some people with hypercoagulable conditions, such as those with Factor V Leiden or antiphospholipid syndrome, might wonder whether red light therapy could serve as an adjunct to reduce their clot risk. The preclinical data are intriguing but nowhere near sufficient to support that use. Clotting disorders are managed with anticoagulants whose dosing has been refined through decades of trials. Adding an uncharacterized phototherapy on top of that regimen, especially one whose dose-response curve is not well defined in humans, would be premature.

Circadian Biology and a Surprising Connection

An emerging line of research connects light exposure to clotting through an unexpected route: the body’s circadian clock. A recent review noted that intense light therapy has been studied for its effects on ischemia-reperfusion injury and clotting disorders through a mechanism involving Period 2, or PER2, a core circadian clock protein.¹⁸ PER2 is involved in regulating metabolism and inflammation in blood vessel walls, and its expression follows a daily rhythm driven by light exposure. This raises the possibility that some of red light therapy’s vascular effects may not be purely local, photon-hits-cell interactions but partly mediated by shifting the body’s internal clock in ways that alter how the vascular system behaves over the course of a day. This research is still largely preclinical, but it suggests the relationship between light and clotting may be more layered than a simple “light relaxes platelets” story.

The circadian angle also means timing could matter. If PER2-mediated pathways contribute to the anti-thrombotic effect, then when during the day you receive light therapy might influence whether it helps, does nothing, or disrupts a carefully tuned biological rhythm. This is speculation built on early-stage science, but it is worth noting because it highlights just how many variables remain unexplored in this field.

1
PubMed Central. Alterations in visible light exposure modulate platelet function and regulate thrombus formation
2
PubMed Central. Low-Level Laser Irradiation Exerts Antiaggregative Effect on Human Platelets Independently on the Nitric Oxide Metabolism and Release of Platelet Activation Markers
3
PubMed Central. Low-level light therapy reduces platelet destruction during extracorporeal circulation
4
Scientific Reports. Low-level light therapy reduces platelet destruction during extracorporeal circulation
5
PubMed Central. Red light stimulates vasodilation through extracellular vesicle trafficking
6
PubMed Central. Red/Near Infrared Light Stimulates Release of an Endothelium Dependent Vasodilator and Rescues Vascular Dysfunction in a Diabetes Model
7
PubMed Central. Low-Level Light Therapy Protects Red Blood Cells Against Oxidative Stress and Hemolysis During Extracorporeal Circulation
8
PubMed. The effect of pulsed IR-light on the rheological parameters of blood in vitro
9
PubMed. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light
10
PubMed. The effects of intravenous laser irradiation of blood with red and blue light on stroke risk biomarkers and neurological function: a double blind randomized controlled trial
11
PubMed Central. Long wavelength light exposure reduces systemic inflammation coagulopathy, and acute organ injury following polytrauma in mice
12
PubMed. Red Light Therapy in Thrombosis and Hemostasis
13
Scientific Reports. The impact of wavelengths of LED light-therapy on endothelial cells
14
PubMed. Clinical applications and molecular mechanisms for intravenous laser blood irradiation: a systematic review
15
PubMed Central. Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods
16
Scientific Reports. Near-infrared photobiomodulation of blood reversibly inhibits platelet reactivity and reduces hemolysis
17
Aesthetic Surgery Journal. Photobiomodulation: The Clinical Applications of Low-Level Light Therapy
18
PubMed Central. Light therapy in medicine: where do we stand?